Related Experiment Video
Updated: May 28, 2026

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease
M Sartori1, E Conti, E Favaretto
1Angiology and Blood Coagulation Unit 'Marino Golinelli', University Hospital S.Orsola-Malpighi, Bologna, Italy. michelangelo.sartori@aosp.bo.it
Insights
Multiple thrombophilic alterations increase the risk of arterial thrombotic events in patients undergoing percutaneous transluminal angioplasty for peripheral arterial disease. This finding highlights the importance of assessing multiple thrombotic risk factors for improved patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Vascular Surgery
Background:
- Limited data exist on thrombophilic risk factors and outcomes after percutaneous transluminal angioplasty (PTA) for peripheral arterial disease (PAD).
- Thrombophilic alterations may influence the clinical course of PAD patients undergoing revascularization procedures.
Purpose of the Study:
- To investigate the prognostic role of specific thrombophilic factors (homocysteine, fibrinogen, Factor VIII, lupus anticoagulant, FII G20210A, FV Leiden) in patients undergoing PTA for PAD.
- To determine the association between thrombophilic alterations and major adverse cardiovascular events (MACE) after PTA.
Main Methods:
- Prospective study involving 230 patients with PAD (Fontaine stages IIb-IV) undergoing PTA.
- Follow-up period of 24.3 months to assess MACE as the composite endpoint.
- Cox regression analysis was used to identify predictors of MACE.
Main Results:
- 96 (41.7%) patients experienced MACE during follow-up.
- Diabetes and critical limb ischemia were independent predictors of MACE.
- While single thrombophilic alterations were not significant predictors, the presence of two or more alterations significantly increased the risk of MACE (HR 2.55-2.91).
Conclusions:
- Multiple thrombophilic alterations are associated with an increased risk of arterial thrombotic events in patients undergoing PTA for PAD.
- These findings suggest that a comprehensive thrombophilia screening may be beneficial for risk stratification in PAD patients undergoing PTA.
Objectives:
Few data are available on thrombophilic risk factors and clinical outcome in patients undergoing percutaneous transluminal angioplasty (PTA) for peripheral arterial disease (PAD). We investigated the role of homocysteine, fibrinogen, Factor VIII (FVIII), lupus anticoagulant (LAC) and FII G20210A, and FV R506Q (FV Leiden) mutations as prognostic factors in 230 patients who underwent PTA for PAD (Fontaine's stages: IIb through IV; aged 69 ± 1 years).
Design And Methods:
A prospective study. Major adverse cardiovascular events (MACE) were the composite 'end' point.
Results:
During the follow-up (24.3 ± 1.5 months), 96 (41.7%) patients reached the 'end' point. According to Cox regression analysis, diabetes and critical limb ischaemia were predictors of MACE, whereas each single thrombophilic alteration was not. Thrombophilic alterations were more frequent in patients that reached the 'end' point, and the patients with two alterations (hazard ratio (HR) 2.55 confidence interval (CI): 1.20-5.46, p = 0.015) and those with three or more alterations (HR 2.91 CI: 1.31-6.45, p = 0.009) had an increased risk for MACE versus those without alterations. Thrombophilic alterations were not associated with limb loss during the follow-up.
Conclusion:
The presence of multiple thrombophilic alterations in patients who underwent PTA for PAD is associated with increased risk of arterial thrombotic events.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
